focus -WSS

focus

author：focus 2025-09-27 22:59:46 - browse：94614

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Colonoscopy at 40? Study finds a possible benefit

WSS

Death of patient in Alzheimer’s trial raises question of possible risks

Traditional Chinese medicine benefits explored in new JAMA study

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Medtronic CEO on promising devices for diabetes, hypertension

Why Sanofi got shellacked over its spinoff

Readout Newsletter: New research from Sanofi, Regeneron, etc.

knowledge

focus

hotspot

Jerome Adams on the need for new antivirals for Covid

In areas with more Black doctors, Black people live longer

Continuity nursing helped my family in our darkest PICU moments

Emergency medicine has repudiated 'excited delirium.' Now what?

How to save PrEP access — and even expand it

Emergency medicine has repudiated 'excited delirium.' Now what?

Dobbs anniversary: the lost opportunity of abortion as health care

The pink breast cancer awareness ribbon needs a redesign

Hollywood unions extend contract negotiations for actors

WHO may add ‘noma' to its list of neglected tropical diseases

focus

#NeedHerScience: shining a light on gender disparities in medicine

Why Sanofi got shellacked over its spinoff

Disclosing genetic information: not as worrisome as once feared

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Paying for Covid pills will soon shift to insurers

WATCH: Why do fingernails fall off when they're damaged?

focus

leisure time

Wikipedia

focus